Artificial intelligence has solved one of biology’s most stubborn mysteries: how proteins fold into their intricate three-dimensional shapes. But as the field shifts from prediction to application, a ...
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
HYDERABAD: The opening day of BioAsia 2026 highlighted the transformative role of artificial intelligence in science and healthcare, alongside deliberations on ...
According to Valuates Reports, The global market for AI in Biotechnology was valued at USD 1033 Million in the year 2024 and is projected to reach a revised size of USD 1971 Million by 2031, growing ...
3don MSNOpinion
AI-biotech sovereignty will define India’s future
India must lead in biotech sovereignty powered by AI. This convergence will shape healthcare, food, and biosecurity. Nations ...
News-Medical.Net on MSN
Disordered lipid nanoparticles enhance RNA delivery efficiency
The tiny fatty capsules that delivered COVID-19 mRNA vaccines into billions of arms may work better when they're a little ...
A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...
University of Missouri researchers have released the world's largest collection of protein models with quality assessment—a groundbreaking new resource that could accelerate drug development for ...
GlobalData on MSN
RNA-targeting small molecules: a new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
Ribosomes, the cell's protein-making factories, consume large amounts of energy as they build the proteins that keep cells alive and functioning. When cells experience stress—such as lack of nutrients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results